PMID- 22705059 OWN - NLM STAT- MEDLINE DCOM- 20130131 LR - 20120821 IS - 1879-2472 (Electronic) IS - 0049-3848 (Linking) VI - 130 IP - 3 DP - 2012 Sep TI - Rapid improvement of renal function in patients with acute pulmonary embolism indicates favorable short term prognosis. PG - e37-42 LID - 10.1016/j.thromres.2012.05.032 [doi] AB - OBJECTIVE: Various clinical and biochemical parameters predict the prognosis of patients with acute pulmonary embolism(APE). Treatment of APE can improve a patient's hemodynamic status, restoring adequate peripheral organ perfusion. Therefore, we hypothesized that improvement of renal function can predict short term prognosis of APE patients. MATERIAL & METHOD: We evaluated 232 consecutive patients (94 men,aged 67 +/- 18 years) with APE proven by spiral computer tomography. Blood samples were collected for creatinine assays on admission and 72 hours later, the glomerular filtration rate(eGFR) was estimated using the MDRD formula. RESULTS: During the first 72 hours, 6 subjects died, while during the first 30 days 24(10%) subjects died (APE mortality 8%). On admission eGFR<60 ml/min was present in 113 patients(49%) and after 72 hours in 85 patients(38%). In 26 patients(11%) eGFR on admission was <60 ml/min and renal function did not improve during subsequent 72 hours. In this group the 30-day all-cause and APE-related mortality rates were 27% and 23%, respectively, while serious adverse events occurred in 38% of them. 206 patients with eGFR>60 ml/min showed a more favorable prognosis (8% 30-day all-cause mortality) than subjects with eGFR<60 ml/min and a stable eGFR during the first 72 hours (27% mortality rate, p<0.003). Persistent renal dysfunction predicted all-cause and PE-related 30-day mortality (hazard risk 2.53(CI 95%:0.96-6.68),p=0.06 and 3.04(CI 95%:1.28-7.26),p=0.01, respectively). CONCLUSION: Approximately 50% of patients with APE have at least a moderately impaired renal function on admission. Renal function improves within 72 hours in patients with a good prognosis, while "persistent" renal dysfunction indicates an increased mortality. CI - Copyright (c) 2012 Elsevier Ltd. All rights reserved. FAU - Kostrubiec, Maciej AU - Kostrubiec M AD - Department of Internal Medicine and Cardiology, The Medical University of Warsaw, Poland. maciej.kostrubiec@wum.edu.pl FAU - Labyk, Andrzej AU - Labyk A FAU - Pedowska-Wloszek, Justyna AU - Pedowska-Wloszek J FAU - Pacho, Szymon AU - Pacho S FAU - Dzikowska-Diduch, Olga AU - Dzikowska-Diduch O FAU - Dul, Przemyslaw AU - Dul P FAU - Ciurzynski, Michal AU - Ciurzynski M FAU - Bienias, Piotr AU - Bienias P FAU - Pruszczyk, Piotr AU - Pruszczyk P LA - eng PT - Clinical Trial PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120616 PL - United States TA - Thromb Res JT - Thrombosis research JID - 0326377 SB - IM MH - Acute Disease MH - Aged MH - Comorbidity MH - Female MH - *Glomerular Filtration Rate MH - Humans MH - Incidence MH - Kidney Diseases/*diagnosis/*mortality MH - Male MH - Poland/epidemiology MH - Prognosis MH - Pulmonary Embolism/*diagnosis/*mortality MH - Recovery of Function MH - Reproducibility of Results MH - Risk Assessment MH - Sensitivity and Specificity MH - Survival Analysis MH - Survival Rate MH - Treatment Outcome EDAT- 2012/06/19 06:00 MHDA- 2013/02/01 06:00 CRDT- 2012/06/19 06:00 PHST- 2011/12/15 00:00 [received] PHST- 2012/05/14 00:00 [revised] PHST- 2012/05/26 00:00 [accepted] PHST- 2012/06/19 06:00 [entrez] PHST- 2012/06/19 06:00 [pubmed] PHST- 2013/02/01 06:00 [medline] AID - S0049-3848(12)00270-8 [pii] AID - 10.1016/j.thromres.2012.05.032 [doi] PST - ppublish SO - Thromb Res. 2012 Sep;130(3):e37-42. doi: 10.1016/j.thromres.2012.05.032. Epub 2012 Jun 16.